Abivax CEO highlights pipeline assets, including lead HIV drug
Dec 7, 2017
Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for its lead clinical-stage molecule against...
Insight
To build a great biopharma deal, don't worry, be happy
Big pharma wants you to be happy. After grilling you with 200 questions about your biotech project, sending an army of experts to trample through your data, dragging your team through a grinding due diligence and then running up and down your supply chain, at the end of the day this outsized partner wants to hear you are pleased with the engagement it is proposing.
Dec 7, 2017
Digital Health faces formidable hurdles in chronic disease management
Nov 13, 2017
Bringing healthcare into the digital age would create a greenfield opportunity, opening vast opportunities for devices and drugs. Yet before companies can start open field...
partnering360®: leverage and cultivate your dealmaker network
partnering360 is the network for dealmakers in the life science industry. This global community of more than 43,000 is constantly growing, and the partnering opportunities continually updating.
partnering360 database
Find your preferred partners in our database of life science executives, companies and licensing opportunities.
Events on partnering360
Gain access to people that attend the following events:
partnering360 companies
Click on the image to access all available company profiles via our map.
The poor and constantly worsening compliance is a big issue in conditions where missed pills do not lead to direct sy...